Veristat supports successful pre-approval and post-market pharmacovigilance (PV) and Medical Information (MI) expertise for pharmaceutical drugs (brand and generic), biologics, radiopharmaceutical drugs, natural health products, and medical devices.
Under the continued leadership of Agnes Jankowicz, our experienced experts deliver pharmacovigilance services at all levels, including specialists, senior consultants, strategists, and safety physicians.
With the acquisition of SFL (Solutions for Life Sciences), Veristat expands its Pharmacovigilance expertise into Europe.
